SethJoelFieldMDPhD
Endocrinology • Cleveland, OHDiabetes, Lipid Metabolism
Professor of Medicine/Endocrinology, Case Western Reserve University Investigator, Harrington Discovery Institute, University Hospitals Cleveland Medical Center
Dr. Field is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UH Cleveland Medical Center
11100 Euclid Ave Department of Medicine-Endocrinology
Cleveland, OH 44106Phone+1 216-844-8500Fax+1 216-844-3120
Education & Training
Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
University of Pennsylvania Health SystemResidency, Internal Medicine, 1997 - 1999
Harvard Medical SchoolClass of 1997
Certifications & Licensure
CA State Medical License 2005 - 2026
OH State Medical License 2020 - 2026
MA State Medical License 1999 - 2005
PA State Medical License 1998 - 1999
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- 9 citationsA multienzyme S-nitrosylation cascade regulates cholesterol homeostasis.Colin T Stomberski, Nicholas M Venetos, Hua-Lin Zhou, Zhaoxia Qian, Bryce R Collison
Cell Reports. 2022-10-25 - 13 citationsCholesterol Efflux-Independent Modification of Lipid Rafts by AIBP (Apolipoprotein A-I Binding Protein).Hann Low, Nigora Mukhamedova, Luciano Dos Santos Aggum Capettini, Yining Xia, Irena Carmichael
Arteriosclerosis, Thrombosis, and Vascular Biology. 2020-08-13 - 9 citationsInduction of membrane curvature by proteins involved in Golgi trafficking.Stefanie L. Makowski, Ramya S. Kuna, Seth J. Field
Advances in Biological Regulation. 2020-01-01
Grant Support
- Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer AgentCASE WESTERN RESERVE UNIVERSITY2020–2025
- Targeting A Novel Phosphoinositide Signaling Pathway For Cancer TherapyNational Cancer Institute2009–2010
- Phosphoinositides Provide Unique Insights Into Cell Biology And PathophysiologyOffice Of The Director, National Institutes Of Health2008
- Pi-3-Kinase Signaling Over Physiologic Time-Scales/Response To Insulin Or IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2006–2007
- Pi-3-Kinase Mediated Signaling By Insulin And IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2004–2007
- Pi-3-Kinase Mediated Signaling By Insulin And IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
